Poly (ADP-Ribose) Polymerase Inhibitor Activity in Prostate Cancers Harboring Mutations in DNA Repair Genes: Who Benefits?

被引：5

作者：

Ganesan, Shridar ^{[1
]}

Garber, Judy ^{[2
]}

机构：

[1] Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

JCO PRECISION ONCOLOGY | 2020年 / 4卷

关键词：

BRCA1;

D O I：

10.1200/PO.20.00269

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1034 / 1037

页数：4

共 25 条

[1] Significant Tumor Response to the Poly (ADP-ribose) Polymerase Inhibitor Olaparib in Heavily Pretreated Patient With Ovarian Carcinosarcoma Harboring a Germline RAD51D Mutation [J].

Chandran, Elias A. ;

Kennedy, Ian .

JCO PRECISION ONCOLOGY, 2018, 2 :1-4

[2] Biomarker-Guided Development of DNA Repair Inhibitors [J].

Cleary, James M. ;

Aguirre, Andrew J. ;

Shapiro, Geoffrey I. ;

D'Andrea, Alan D. .

MOLECULAR CELL, 2020, 78 (06) :1070-1085

[3] HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures [J].

Davies, Helen ;

Glodzik, Dominik ;

Morganella, Sandro ;

Yates, Lucy R. ;

Staaf, Johan ;

Zou, Xueqing ;

Ramakrishna, Manasa ;

Martin, Sancha ;

Boyault, Sandrine ;

Sieuwerts, Anieta M. ;

Simpson, Peter T. ;

King, Tari A. ;

Raine, Keiran ;

Eyfjord, Jorunn E. ;

Kong, Gu ;

Borg, Ake ;

Birney, Ewan ;

Stunnenberg, Hendrik G. ;

van de Vijver, Marc J. ;

Borresen-Dale, Anne-Lise ;

Martens, John W. M. ;

Span, Paul N. ;

Lakhani, Sunil R. ;

Vincent-Salomon, Anne ;

Sotiriou, Christos ;

Tutt, Andrew ;

Thompson, Alastair M. ;

Van Laere, Steven ;

Richardson, Andrea L. ;

Viari, Alain ;

Campbell, Peter J. ;

Stratton, Michael R. ;

Nik-Zainal, Serena .

NATURE MEDICINE, 2017, 23 (04) :517-+

[4] Olaparib for Metastatic Castration-Resistant Prostate Cancer [J].

de Bono, J. ;

Mateo, J. ;

Fizazi, K. ;

Saad, F. ;

Shore, N. ;

Sandhu, S. ;

Chi, K. N. ;

Sartor, O. ;

Agarwal, N. ;

Olmos, D. ;

Thiery-Vuillemin, A. ;

Twardowski, P. ;

Mehra, N. ;

Goessl, C. ;

Kang, J. ;

Burgents, J. ;

Wu, W. ;

Kohlmann, A. ;

Adelman, C. A. ;

Hussain, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2091-2102

[5] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].

Fong, Peter C. ;

Boss, David S. ;

Yap, Timothy A. ;

Tutt, Andrew ;

Wu, Peijun ;

Mergui-Roelvink, Marja ;

Mortimer, Peter ;

Swaisland, Helen ;

Lau, Alan ;

O'Connor, Mark J. ;

Ashworth, Alan ;

Carmichael, James ;

Kaye, Stan B. ;

Schellens, Jan H. M. ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134

[6] Tumor Suppressor Tolerance: Reversion Mutations in BRCA1 and BRCA2 and Resistance to PARP Inhibitors and Platinum [J].

Ganesan, Shridar .

JCO PRECISION ONCOLOGY, 2018, 2

[7] Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer [J].

Golan, Talia ;

Hammel, Pascal ;

Reni, Michele ;

Van Cutsem, Eric ;

Macarulla, Teresa ;

Hall, Michael J. ;

Park, Joon-Oh ;

Hochhauser, Daniel ;

Arnold, Dirk ;

Oh, Do-Youn ;

Reinacher-Schick, Anke ;

Tortora, Giampaolo ;

Alguel, Hana ;

O'Reilly, Eileen M. ;

McGuinness, David ;

Cui, Karen Y. ;

Schlienger, Katia ;

Locker, Gershon Y. ;

Kindler, Hedy L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04) :317-327

[8] Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer [J].

Gonzalez-Martin, A. ;

Pothuri, B. ;

Vergote, I. ;

DePont Christensen, R. ;

Graybill, W. ;

Mirza, M. R. ;

McCormick, C. ;

Lorusso, D. ;

Hoskins, P. ;

Freyer, G. ;

Baumann, K. ;

Jardon, K. ;

Redondo, A. ;

Moore, R. G. ;

Vulsteke, C. ;

O'Cearbhaill, R. E. ;

Lund, B. ;

Backes, F. ;

Barretina-Ginesta, P. ;

Haggerty, A. F. ;

Rubio-Perez, M. J. ;

Shahin, M. S. ;

Mangili, G. ;

Bradley, W. H. ;

Bruchim, I. ;

Sun, K. ;

Malinowska, I. A. ;

Li, Y. ;

Gupta, D. ;

Monk, B. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25) :2391-2402

[9] Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in BRCA1 and BRCA2 wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes. [J].

Gruber, Joshua James ;

Afghahi, Anosheh ;

Hatton, Alyssa ;

Scott, Danika ;

McMillan, Alex ;

Ford, James M. ;

Telli, Melinda L. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[10] Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance [J].

Horak, Peter ;

Weischenfeldt, Joachim ;

von Amsberg, Gunhild ;

Beyer, Burkhard ;

Schuette, Andreas ;

Uhrig, Sebastian ;

Gieldon, Laura ;

Klink, Barbara ;

Feuerbach, Lars ;

Huebschmann, Daniel ;

Kreutzfeldt, Simon ;

Heining, Christoph ;

Maier, Sebastian ;

Hutter, Barbara ;

Penzel, Roland ;

Schlesner, Matthias ;

Eils, Roland ;

Sauter, Guido ;

Stenzinger, Albrecht ;

Brors, Benedikt ;

Schroeck, Evelin ;

Glimm, Hanno ;

Froehling, Stefan ;

Schlomm, Thorsten .

COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2019, 5 (02)

← 1 2 3 →